World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
115
Citations
71592
World Ranking
4445
National Ranking
2423

Daniel J. Hicklin publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Daniel J. Hicklin sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 282 publications — 13th percentile

13% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Daniel J. Hicklin D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Daniel J. Hicklin sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 115 D-Index — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Daniel J. Hicklin is affiliated with Eli Lilly in the United States. Their research primarily focuses on fields within Medicine and Biochemistry, Genetics and Molecular Biology, with a specific emphasis on Oncology, Immunology, Radiology, Nuclear Medicine and Imaging, Biotechnology, and Genetics.

The scientist has contributed extensively to the study of CAR-T cell therapy research and monoclonal and polyclonal antibodies research. Other notable research topics include cancer research and treatments, immunotherapy and immune responses, cancer immunotherapy and biomarkers, immune cell function and interaction, and virus-based gene therapy research.

Daniel J. Hicklin has a record of publications in several scientific venues. Frequent publication venues include:

  • Regular and Young Investigator Award Abstracts
  • Cancer Research
  • Cancer Immunology Research
  • Cancer Treatment and Research Communications
  • Blood

Their recent papers cover various aspects of immunotherapy and tumor biology. Selected recent publications include:

  • mWTX-330, an IL-12 INDUKINE Molecule, Activates and Reshapes Tumor-Infiltrating CD8+ T and NK Cells to Generate Antitumor Immunity, 2023, Cancer Immunology Research
  • Characterization of ASP8374, a fully-human, antagonistic anti-TIGIT monoclonal antibody, 2021, Cancer Treatment and Research Communications
  • Conditionally Activated IL-12 or IFNα Indukine™ Molecules Inhibit Syngeneic Lymphoma Tumor Growth in Mice, Induce Anti-Tumor Immune Responses and Are Tolerated in Non-Human Primates, 2021, Blood
  • 715 WTX-330 is an IL-12 pro-drug that is conditionally activated within the tumor microenvironment and induces regressions in mouse tumor models, 2021, Regular and Young Investigator Award Abstracts
  • 718 WTX-124 is a novel IL-2 pro-drug that is conditionally activated in tumors and drives antitumor immunity in murine syngeneic cancer models, 2021, Regular and Young Investigator Award Abstracts

The scientist frequently collaborates with several co-authors, including:

  • Andrés Salmerón
  • Christopher J. Nirschl
  • William M. Winston
  • Heather R. Brodkin
  • Jenna M. Sullivan

Best Publications

  • Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis

    Daniel J. Hicklin;Lee M. Ellis

  • VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

    Rosandra N. Kaplan;Rebecca D. Riba;Stergios Zacharoulis;Anna H. Bramley

  • Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors

    Mario Peichev;Afzal J. Naiyer;Daniel Pereira;Zhenping Zhu

  • mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt

    Kathryn E. O'Reilly;Fredi Rojo;Qing Bai She;David Solit

  • Impaired recruitment of bone-marrow–derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

    David Lyden;Koichi Hattori;Koichi Hattori;Sergio Dias;Carla Costa

  • Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions

    Peter Carmeliet;Lieve Moons;Aernout Luttun;Valeria Vincenti

  • VEGF-targeted therapy: mechanisms of anti-tumour activity

    Lee M. Ellis;Daniel J. Hicklin

  • Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

    Oriol Casanovas;Daniel J. Hicklin;Gabriele Bergers;Douglas Hanahan

  • Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose

    Christine H. Chung;Beloo Mirakhur;Emily Chan;Quynh Thu Le

  • Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.

    Francesco M. Marincola;Elizabeth M. Jaffee;Daniel J. Hicklin;Soldano Ferrone

  • Vascular Normalization by Vascular Endothelial Growth Factor Receptor 2 Blockade Induces a Pressure Gradient Across the Vasculature and Improves Drug Penetration in Tumors

    Ricky T. Tong;Yves Boucher;Sergey V. Kozin;Frank Winkler

  • Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases.

    Frank Winkler;Sergey V. Kozin;Ricky T. Tong;Sung-Suk Chae

  • Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

    Giannoula Klement;Sylvain Baruchel;Janusz Rak;Shan Man

  • Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1

    Aernout Luttun;Marc Tjwa;Lieve Moons;Yan Wu

  • Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration

    B. Oosthuyse;L. Moons;E. Storkebaum;H. Beck

  • Vascular Trauma Induces Rapid but Transient Mobilization of VEGFR2+AC133+ Endothelial Precursor Cells

    Muhammad Gill;Sergio Dias;Koichi Hattori;Mary Lee Rivera

  • Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1

    Monica Autiero;Johannes Waltenberger;Didier Communi;Andrea Kranz

  • Vascular Endothelial Growth Factor and Angiopoietin-1 Stimulate Postnatal Hematopoiesis by Recruitment of Vasculogenic and Hematopoietic Stem Cells

    Koichi Hattori;Sergio Dias;Beate Heissig;Neil R. Hackett

  • Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis.

    Scott T. Avecilla;Koichi Hattori;Beate Heissig;Rafael Tejada

  • Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1 + stem cells from bone-marrow microenvironment

    Koichi Hattori;Beate Heissig;Yan Wu;Sergio Dias

Frequent Co-Authors

Peter Bohlen
Peter Bohlen Eli Lilly (United States)
Lee M. Ellis
Lee M. Ellis The University of Texas MD Anderson Cancer Center
Robert S. Kerbel
Robert S. Kerbel University of Toronto
Shahin Rafii
Shahin Rafii Cornell University
Soldano Ferrone
Soldano Ferrone Harvard University
David Lyden
David Lyden Cornell University
Malcolm A.S. Moore
Malcolm A.S. Moore Memorial Sloan Kettering Cancer Center
Neil R. Hackett
Neil R. Hackett Cornell University
Rakesh K. Jain
Rakesh K. Jain Harvard University
Elisabetta Dejana
Elisabetta Dejana Uppsala University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens doors to several other rewarding healthcare fields and educational tracks available online. For those looking to start their journey with practical nursing, it’s important to ask, do I need to take the teas test for lpn? Some schools have flexible admissions, making entry into nursing easier for aspiring professionals.

If your interests lie in healthcare management, consider pursuing a degree in healthcare administration. This pathway prepares you for leadership roles within hospitals and clinics—all offered through convenient online programs.

Registered nurses aiming to advance their careers can explore asn to fnp programs, which allow a seamless transition to becoming a Family Nurse Practitioner without repeating undergraduate coursework.

Additionally, a growing field for those interested in wellness and nutrition is accessible through online nutrition degree programs. These degrees serve as a stepping stone to numerous opportunities in patient education and dietary planning.

Best Scientists Citing Daniel J. Hicklin

Trending Scientists

Recently Published Articles